Moleculin Reports Second Quarter 2023 Financial Results

Go back to Moleculin Reports Second Quarter 2023 Financial Results
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.57 +0.05 (9.62%)
Previous Close $0.52    52 Week High $9.58 
Open $0.54    52 Week Low $2.34 
Day High $0.58    P/E N/A 
Day Low $0.53    EPS $-0.34 
Volume 1,313,488